Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Statistical Methods in Integrative Genomics.

Richardson S, Tseng GC, Sun W.

Annu Rev Stat Appl. 2016 Jun;3:181-209. Epub 2016 Apr 18.

2.

Inclusion body myositis.

Dimachkie MM, Barohn RJ.

Neurol Clin. 2014 Aug;32(3):629-46, vii. doi: 10.1016/j.ncl.2014.04.001. Epub 2014 Jun 6. Review.

3.

Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation.

Vafiadaki E, Arvanitis DA, Papalouka V, Terzis G, Roumeliotis TI, Spengos K, Garbis SD, Manta P, Kranias EG, Sanoudou D.

FEBS J. 2014 Jul;281(14):3261-79. doi: 10.1111/febs.12859. Epub 2014 Jun 11.

4.

Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.

Paco S, Kalko SG, Jou C, Rodríguez MA, Corbera J, Muntoni F, Feng L, Rivas E, Torner F, Gualandi F, Gomez-Foix AM, Ferrer A, Ortez C, Nascimento A, Colomer J, Jimenez-Mallebrera C.

PLoS One. 2013 Oct 11;8(10):e77430. doi: 10.1371/journal.pone.0077430. eCollection 2013. Erratum in: PLoS One. 2015;10(5):e0128614.

5.

Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15.

Franzi S, Salajegheh M, Nazareno R, Greenberg SA.

PLoS One. 2013 Jun 4;8(6):e65362. doi: 10.1371/journal.pone.0065362. Print 2013.

6.

Genomic signatures characterize leukocyte infiltration in myositis muscles.

Zhu W, Streicher K, Shen N, Higgs BW, Morehouse C, Greenlees L, Amato AA, Ranade K, Richman L, Fiorentino D, Jallal B, Greenberg SA, Yao Y.

BMC Med Genomics. 2012 Nov 21;5:53. doi: 10.1186/1755-8794-5-53.

7.

Inclusion body myositis.

Dimachkie MM, Barohn RJ.

Semin Neurol. 2012 Jul;32(3):237-45. doi: 10.1055/s-0032-1329197. Epub 2012 Nov 1. Review.

8.

Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr, Kunkel LM, Wagner KR.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16234-9. doi: 10.1073/pnas.1209508109. Epub 2012 Sep 17.

9.

Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.

Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R, Cubeddu T, Laschena F, Ottaviani P, Ricci E.

PLoS One. 2012;7(6):e38779. doi: 10.1371/journal.pone.0038779. Epub 2012 Jun 13.

10.

Global gene profiling of VCP-associated inclusion body myopathy.

Nalbandian A, Ghimbovschi S, Radom-Aizik S, Dec E, Vesa J, Martin B, Knoblach S, Smith C, Hoffman E, Kimonis VE.

Clin Transl Sci. 2012 Jun;5(3):226-34. doi: 10.1111/j.1752-8062.2012.00407.x. Epub 2012 Apr 4.

11.

Autoimmune neuromuscular disorders.

Kraker J, Zivković SA.

Curr Neuropharmacol. 2011 Sep;9(3):400-8. doi: 10.2174/157015911796558000.

12.

The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.

De Paepe B, Creus KK, De Bleecker JL.

Clin Dev Immunol. 2012;2012:369432. doi: 10.1155/2012/369432. Epub 2011 Oct 23. Review.

13.

Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.

Ivanidze J, Hoffmann R, Lochmüller H, Engel AG, Hohlfeld R, Dornmair K.

Am J Pathol. 2011 Sep;179(3):1347-59. doi: 10.1016/j.ajpath.2011.05.055.

14.

Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.

Kim JS, Werth VP.

J Histochem Cytochem. 2011 Aug;59(8):780-90. doi: 10.1369/0022155411411304.

15.

Recent advances in the immunogenetics of idiopathic inflammatory myopathy.

Chinoy H, Lamb JA, Ollier WE, Cooper RG.

Arthritis Res Ther. 2011 May 26;13(3):216. doi: 10.1186/ar3327. Review.

16.

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis.

Salajegheh M, Lam T, Greenberg SA.

PLoS One. 2011;6(5):e20266. doi: 10.1371/journal.pone.0020266. Epub 2011 May 23.

17.

Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?

Rider LG, Miller FW.

Arthritis Rheum. 2010 Sep;62(9):2619-22. doi: 10.1002/art.27525. No abstract available.

18.

Theories of the pathogenesis of inclusion body myositis.

Greenberg SA.

Curr Rheumatol Rep. 2010 Jun;12(3):221-8. doi: 10.1007/s11926-010-0102-5. Review.

19.

Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.

Salajegheh M, Kong SW, Pinkus JL, Walsh RJ, Liao A, Nazareno R, Amato AA, Krastins B, Morehouse C, Higgs BW, Jallal B, Yao Y, Sarracino DA, Parker KC, Greenberg SA.

Ann Neurol. 2010 Jan;67(1):53-63. doi: 10.1002/ana.21805.

20.

Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice.

Sanoudou D, Duka A, Drosatos K, Hayes KC, Zannis VI.

Pharmacogenomics J. 2010 Jun;10(3):165-79. doi: 10.1038/tpj.2009.51. Epub 2009 Dec 1.

Supplemental Content

Support Center